Clinical trials
COVID-19 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 20 |
| 2021 | 17 |
| 2022 | 11 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 26 |
| Completed | 20 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 17 |
| Chinese University of Hong Kong | 13 |
| The Hong Kong Polytechnic University | 5 |
| Hong Kong Baptist University | 3 |
| DreamTec Research Limited | 2 |
| Gilead Sciences | 2 |
| AstraZeneca | 1 |
| China National Biotec Group Company Limited | 1 |
| Ensemble Group Holdings, LLC | 1 |
| Hong Kong Sanatorium & Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 53 |
| Coronavirus Infections | 4 |
| Anxiety Disorders | 2 |
| Influenza, Human | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Anosmia | 1 |
| Emergencies | 1 |
| Fatigue | 1 |
| Immunoglobulin G4-Related Disease | 1 |
| Infections | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.